Literature DB >> 12044249

Psychiatric symptoms in Parkinson's disease.

Karen E Anderson1, William J Weiner.   

Abstract

Aside from the well-known triad of resting tremor, postural instability, and bradykinesia, Parkinson's disease (PD) patients may also develop psychiatric illness as a part of their disease. The psychiatric symptoms may be as disabling as the movement disorder, but are often amenable to treatment. We review the most recent investigations of mood disorders, anxiety disorders, and hallucinations/ psychosis in PD. We then highlight new treatment studies for hallucinations/psychosis in PD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12044249     DOI: 10.1007/s11910-002-0005-6

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  56 in total

1.  SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study.

Authors:  G Dell'Agnello; R Ceravolo; A Nuti; G Bellini; A Piccinni; C D'Avino; L Dell'Osso; U Bonuccelli
Journal:  Clin Neuropharmacol       Date:  2001 Jul-Aug       Impact factor: 1.592

Review 2.  Obsessive-compulsive disorder: evidence for basal ganglia dysfunction.

Authors:  J L Rapoport; S P Wise
Journal:  Psychopharmacol Bull       Date:  1988

Review 3.  Theoretical implications of the use of L-dopa in parkinsonism. A review.

Authors:  H Klawans; M M Ilahi; D Shenker
Journal:  Acta Neurol Scand       Date:  1970       Impact factor: 3.209

4.  Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease.

Authors:  G M Halliday; P C Blumbergs; R G Cotton; W W Blessing; L B Geffen
Journal:  Brain Res       Date:  1990-02-26       Impact factor: 3.252

Review 5.  Anxiety and Parkinson's disease.

Authors:  I H Richard; R B Schiffer; R Kurlan
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1996       Impact factor: 2.198

6.  Depression in Parkinson's disease.

Authors:  S E Starkstein; T J Preziosi; P L Bolduc; R G Robinson
Journal:  J Nerv Ment Dis       Date:  1990-01       Impact factor: 2.254

7.  Psychotic complications of long-term levodopa treatment of Parkinson's disease.

Authors:  A Friedman; J Sienkiewicz
Journal:  Acta Neurol Scand       Date:  1991-08       Impact factor: 3.209

8.  A Golgi study of human locus coeruleus in normal brains and in Parkinson's disease.

Authors:  S Patt; L Gerhard
Journal:  Neuropathol Appl Neurobiol       Date:  1993-12       Impact factor: 8.090

9.  Parkinson's disease and anxiety: comorbidity with depression.

Authors:  M A Menza; D E Robertson-Hoffman; A S Bonapace
Journal:  Biol Psychiatry       Date:  1993-10-01       Impact factor: 13.382

10.  "Panic attacks" in Parkinson's disease. A long-term complication of levodopa therapy.

Authors:  A Vázquez; F J Jiménez-Jiménez; P García-Ruiz; D García-Urra
Journal:  Acta Neurol Scand       Date:  1993-01       Impact factor: 3.209

View more
  1 in total

Review 1.  Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson's disease.

Authors:  Vincenzo Bonifati; Ben A Oostra; Peter Heutink
Journal:  J Mol Med (Berl)       Date:  2004-01-08       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.